During Breast Cancer Awareness Month, IceCure’s VP of Business Development and Global Marketing, Tlalit Bussi Tel Tzure, was featured in a Forbes Business Development Council Article entitled “Breast Cancer Awareness Month: How Care Has Transformed in 2020.” The article shares Tlalit’s firsthand insights on how the health system, faced with unprecedented challenges during the COVID-19 pandemic, has rapidly evolved to develop new breast cancer treatment and diagnostic solutions.
Under COVID-19, many women faced delayed treatments for their breast cancer as hospitals were often over capacity. Critical surgeries to excise (remove) breast cancer, such as lumpectomy and mastectomy were postponed. Chemotherapy and radiation treatments were also delayed.
So how did hospitals and healthcare systems start to address the needs of their breast cancer patients. New safety protocols were put in place to keep breast cancer patients at lower risk of infection when at treatment facilities. Telemedicine was implemented whenever possible.
Minimally invasive treatments, like cryoablation*, that could be performed in the office and not in the surgical suite were seen as a new possibility. With many now interested in cryoablation, IceCure’s team had to find a new way to teach our distributors and customers through remote training as traveling became cumbersome and completely impossible at times.
There is still much to be done on the backlog of breast cancer screening that occurred during COVID-19. The success of treatment for breast cancer often depends on how quickly one can be diagnosed and to received care with tumors are still small. However, we should be proud of our accomplishments in treating breast cancer patients under such difficult circumstances.
*IceCure Medical, LTD’s cryoablation systems are not currently cleared for breast cancer treatment in the U.S. Please check that the clinical indications discussed in this case study have regulatory clearance for use in your country.
Please check that the clinical indications discussed in this case study have regulatory clearance for use in your country.
